|
FAM119B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76192394008012E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0458300891969E-13 |
| Normal-vs-Stage2 |
5.353600E-02 |
| Normal-vs-Stage3 |
1.2534417948018E-13 |
| Normal-vs-Stage4 |
4.27435864480685E-14 |
| Stage1-vs-Stage2 |
1.301790E-02 |
| Stage1-vs-Stage3 |
3.434400E-01 |
| Stage1-vs-Stage4 |
2.020200E-02 |
| Stage2-vs-Stage3 |
4.979100E-03 |
| Stage2-vs-Stage4 |
8.774500E-04 |
| Stage3-vs-Stage4 |
2.526200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68753899743024E-14 |
| Normal-vs-AfricanAmerican |
6.16369999999478E-05 |
| Normal-vs-Asian |
2.89079871151898E-11 |
| Caucasian-vs-AfricanAmerican |
3.804400E-01 |
| Caucasian-vs-Asian |
9.789600E-01 |
| AfricanAmerican-vs-Asian |
3.879000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.36689947828029E-10 |
| Normal-vs-Female |
1.77491354946824E-12 |
| Male-vs-Female |
6.330000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(41-60Yrs) |
6.75709488362486E-11 |
| Normal-vs-Age(61-80Yrs) |
1.01419999998242E-06 |
| Normal-vs-Age(81-100Yrs) |
2.862100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.381190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.603700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.524800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.585400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.724400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.561000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.203680E-02 |
| Classical-VS-Follicular |
1.77823999999438E-05 |
| Classical-VS-Other |
6.551200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.23329999838163E-08 |
| Tall-VS-Other |
7.569800E-01 |
| Tall-VS-Normal |
7.7715611723761E-15 |
| Follicular-VS-Other |
1.032370E-01 |
| Follicular-VS-Normal |
1.238120E-02 |
| Other-VS-Normal |
5.587400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.26499996325691E-09 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.98530000000896E-07 |
|
|
